Abstract:Background Metabolic reprogramming in cancer cells is likely to interact with the epigenetic landmarks, which may modulate tumorigenesis. However, the exact mechanism is still largely unknown. In our previous study, inhibition of activity of mechanistic target of rapamycin (mTORC1), a nutrient sensor that affects cellular metabolism, was able to attenuate the DNA methylation level. In this study, we aim to clarify the correlation between the metabolism and DNA methylation and evaluate their interactive roles in the pathogenesis of hepatocellular carcinoma (HCC). Methods We treated HCC cell lines with rapamycin to inhibit mTORC1 activity and performed immunofluorescence (IF) and Enzyme-linked immune sorbent assay (ELISA) to detect the levels of 5-methylcytosine (5-mC). Western-blot and IF assays were used to detect the protein levels of DNA methyltransferases (DNMTs) and RT-PCR was performed to test transcription of DNMTs. Cycloheximide was used to suppress the protein translation. Moreover, MG132 and BafA1 were used to inhibit the functions of ubiquitin-proteasome and autophagy-lysosome respectively to evaluate the effect of posttranslational modification for DNMTs degradation. Finally, we selected twenty liver cancer cell lines and combined western-blot and CCK8 assays to observe the association between mTORC1 inhibition-induced DNMTs degradation and cell viabilities. Results Rapamycin treatment reduced 5 mC levels in HCC cell lines. In parallel, mTORC1 inhibition attenuated the expressions of DNMT1. The subsequent experiments revealed that transcriptional regulation and posttranslational modification is not likely to participate in the process of DNMT1 degradation induced by mTORC1 inhibition. However, cycloheximide half-life assay indicated that mTORC1 might adjust the expression DNMT1 through regulating initial translational efficiency. We found that mTORC1-mediated DNMT1 degradation is closely linked to cell proliferation. Conclusions In conclusion, we demonstrated that mTORC1 could affect DNA methylation levels in HCC probably through regulating DNMTs expression. Besides, this interactive role seems to be closely linked to HCC cell viability. Investigation of the relationship between mTORC1 signalling and DNA methylation will deepen our insight on the pathogenesis of HCC and develop a novel therapeutic strategy for HCC patients.

Coupled Down-Regulation of Mtor and Telomerase Activity During Fluorouracil-Induced Apoptosis of Hepatocarcinoma Cells

Synergistic effect of mTOR inhibitor rapamycin and fluorouracil in inducing apoptosis and cell senescence in hepatocarcinoma cells.

Interferon-α in Combination with Homoharringtonine Induces K562 Cell Apoptosis Through Down-Regulating Human Telomerase Reverse Transcriptase Expression and Telomerase Activity

[Down-Regulation of Mtor Activity and Survivin Expression During Tamoxifen-Induced Apoptosis in Hepatoblastoma Cells].

Andrographolide Enhances 5-Fluorouracil-induced Apoptosis Via Caspase-8-dependent Mitochondrial Pathway Involving P53 Participation in Hepatocellular Carcinoma (SMMC-7721) Cells.

Down-regulation of Sonic Hedgehog Signaling Pathway Activity is Involved in 5-Fluorouracil-induced Apoptosis and Motility Inhibition in Hep3B Cells

5-Fluorouracil Nanoparticles Inhibit Hepatocellular Carcinoma Via Activation of the P53 Pathway in the Orthotopic Transplant Mouse Model

Combination Of Interferon-Alpha And 5-Fluorouracil Induces Apoptosis Through Mitochondrial Pathway In Hepatocellular Carcinoma In Vitro

Combination of Interferon-Α and 5-Fluorouracil Induces Apoptosis Through Mitochondrial Pathway in Hepatocellular Carcinoma in Vitro.

Targeting Pcdh20 Gene by Microrna-122 Confers 5-Fu Resistance in Hepatic Carcinoma

MicroRNA-302a enhances 5-fluorouracil sensitivity in HepG2 cells by increasing AKT/ULK1-dependent autophagy-mediated apoptosis

IDDF2018-ABS-0140 the Crosstalk of MTORC1 and DNA Methylation in Hepatocellular Carcinoma

Effects of Stat3 Gene Silencing and Rapamycin on Apoptosis in Hepatocarcinoma Cells

MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil.

Data from Inhibition of mTORC2 Induces Cell-Cycle Arrest and Enhances the Cytotoxicity of Doxorubicin by Suppressing MDR1 Expression in HCC Cells

5-Fluorouracil induces apoptosis in nutritional deprived hepatocellular carcinoma through mitochondrial damage

A New Trick for an Old Drug: Mtor Inhibitor Rapamycin Augments the Effect of Fluorouracil on Hepatocellular Carcinoma by Inducing Cell Senescence

Enhancement of anti-tumor effects of 5-fluorouracil on hepatocellular carcinoma by low-intensity ultrasound

Combinational therapy targeting the MET‐mTOR‐ROS loop disrupts mitochondrial autoregulatory machinery of liver cancer

Inhibition of Mtor Suppresses Human Gallbladder Carcinoma Cell Proliferation and Enhances the Cytotoxicity of 5-Fluorouracil by Downregulating MDR1 Expression.